Sodium feredetate
Brand names: Sytron
Sodium feredetate is an oral iron preparation (iron sodium edetate) used to treat and prevent iron-deficiency anaemia, particularly in children where a liquid formulation is useful.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It provides elemental iron in a chelated form that is absorbed from the gut and incorporated into haemoglobin, replenishing iron stores required for erythropoiesis.
Prescribing in practice
- Iron preparations are a leading cause of accidental poisoning in young children, so containers must be stored securely out of reach.
- Absorption is reduced by tea, antacids and some other drugs, so timing relative to meals and interacting medicines should be considered.
- Anaemia should be confirmed as iron-deficient before treatment, and an underlying cause sought.
Monitoring
Check haemoglobin and other iron indices to confirm response and decide when to stop, continuing for a period after normalisation to replenish stores.
Counselling the patient
- It may turn the stools dark and can cause stomach upset, constipation or diarrhoea.
- Keep well out of reach of children, as overdose can be very harmful.
- Take as directed and complete the course to rebuild iron stores.
Evidence & guidelines
Oral iron salts are long-established first-line therapy for uncomplicated iron-deficiency anaemia as reflected in NICE guidance.
Reference: NICE NG8; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- MELD-Na Score · Liver Disease
- MELD-Na Score for Liver Cirrhosis · Hepatology
- Corrected Reticulocyte Count / Reticulocyte Production Index · Anaemia
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO